Pipeline — registered trials by phase
Connected Healthcare for Individuals Living at Home With Chronic Conditions
— · Medication Adherence, Medication Compliance, Medication Nonadherence · Completed · est. 2020-07-31
No registered trials in this stage.
Double Blind Study of Vigabatrin for the Treatment of Cocaine Dependence
— · Cocaine Dependence · Completed · est. 2007-11
Multi-Center Study of Panosyl-Isomaltooligosaccharides Adjunctive to PPI Therapy to Treat GERD
— · Gastroesophageal Reflux · Completed · est. 2026-05-27
No registered trials in this stage.
No approved products listed under this sponsor in Drugs@FDA (partnered or subsidiary products may be listed elsewhere).
Source: ClinicalTrials.gov (trials where Health Catalyst is lead sponsor; 3 active or completed) and Drugs@FDA (0 approved products). Registry data can include older or partnered programs; the company's own pipeline page is the official list.
SEC filings — insider trading forms excluded
- S-82026-09-14Employee stock plan
- 8-K2026-09-14Current report (material event)
- SCHEDULE 13D/A2026-09-08SCHEDULE 13D/A
- 8-K2026-09-08Current report (material event)
- SCHEDULE 13G/A2026-08-14SCHEDULE 13G/A
- 10-Q2026-08-06Quarterly report
- 8-K2026-08-06Current report (material event)
- SCHEDULE 13G/A2026-07-28SCHEDULE 13G/A
- SCHEDULE 13G2026-07-21SCHEDULE 13G
- 8-K2026-07-20Current report (material event)
- SCHEDULE 13D2026-06-22SCHEDULE 13D
- SCHEDULE 13D/A2026-06-08SCHEDULE 13D/A
- 8-K2026-06-04Current report (material event)
- DEFA14A2026-06-03DEFA14A
- DEF 14A2026-06-03Proxy statement
- PRE 14A2026-05-19PRE 14A
- SCHEDULE 13G/A2026-05-15SCHEDULE 13G/A
- 10-Q2026-05-11Quarterly report
- 8-K2026-05-11Current report (material event)
- 10-K/A2026-04-30Annual report (amended)
- 8-K2026-04-30Current report (material event)
- 8-K2026-04-27Current report (material event)
- 8-K2026-04-03Current report (material event)
- SCHEDULE 13G/A2026-03-27SCHEDULE 13G/A
- SCHEDULE 13D/A2026-03-13SCHEDULE 13D/A
- S-82026-03-12Employee stock plan
- 10-K2026-03-12Annual report
- 8-K2026-03-12Current report (material event)
- SCHEDULE 13D/A2026-02-18SCHEDULE 13D/A
- 8-K2026-02-18Current report (material event)
- 8-K2026-01-23Current report (material event)
- SCHEDULE 13D2026-01-21SCHEDULE 13D
- SCHEDULE 13G/A2026-01-14SCHEDULE 13G/A
- 8-K2026-01-12Current report (material event)
- SCHEDULE 13G2025-12-22SCHEDULE 13G
- SCHEDULE 13D2025-12-03SCHEDULE 13D
- 8-K2025-12-02Current report (material event)
- SCHEDULE 13G/A2025-11-14SCHEDULE 13G/A
- 10-Q2025-11-10Quarterly report
- 8-K2025-11-10Current report (material event)
Source: SEC EDGAR. Forms 3/4/5 and 144 (insider transactions) are intentionally left out.